Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists

Angela H.E.M. Maas, Giuseppe Rosano, Renata Cífková, +11

European Heart Journal

HypertensionHormonal ContraceptivePregnancy DisordersSex HormonesGynecology +16

A Randomized Trial of Endometrial Scratching before In Vitro Fertilization

Sarah Lensen, Diana Osavlyuk, Sarah Armstrong, +18

New England Journal of Medicine

The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women

Haitham Hamoda, Nick Panay, Hugo Pedder, +2

Post Reproductive Health

Reproductive SciencesHealth Concern 2020Reproductive HealthGynecologyMenopausal Hormone Therapy +10

The 2013 British Menopause Society & Women’s Health Concern recommendations on hormone replacement therapy

Nick Panay, Haitham Hamoda, Roopen Arya, +1

Menopause international

Reproductive SciencesReproductive HealthGynecologyMenopausal Hormone TherapyFemale Reproductive Function +17

Oogenesis and cell death in human prenatal ovaries: what are the criteria for oocyte selection?

Geraldine Hartshorne, S. Lyrakou, Haitham Hamoda, +2

Molecular Human Reproduction

OocyteFertilityGeneticsCell DeathFemale Reproductive System +17

A Randomized Trial of Mifepristone (10 mg) and Levonorgestrel for Emergency Contraception

Haitham Hamoda, Premila W. Ashok, C. Stalder, +3

Obstetrics and Gynecology

Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society

Ιrene Lambrinoudaki, Eleni Armeni, Dimitrios G. Goulis, +17

Maturitas

Family MedicineQuality Of LifeAgingCare PathwayGynecology +15

A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation

Haitham Hamoda, Premila W. Ashok, Gillian Flett, +1

BJOG An International Journal of Obstetrics & Gynaecology

A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13–20 weeks gestation

Haitham Hamoda, Premila W. Ashok, Gillian Flett, +1

Human Reproduction

Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation

Haitham Hamoda, Premila W. Ashok, Gillian Flett, +1

BJOG An International Journal of Obstetrics & Gynaecology